Holen Sie sich die Stockscreener-App
5.20
4.76%
-0.26
Handel nachbörslich:
5.34
0.14
+2.69%
Schlusskurs vom Vortag:
$5.46
Offen:
$5.59
24-Stunden-Volumen:
14,343
Relative Volume:
0.14
Marktkapitalisierung:
$6.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.03M
KGV:
-0.5834
EPS:
-8.9134
Netto-Cashflow:
$-8.20M
1W Leistung:
-6.98%
1M Leistung:
+4.63%
6M Leistung:
-16.53%
1J Leistung:
+67.20%
1-Tages-Spanne:
$5.17
$5.59
1-Wochen-Bereich:
$5.17
$5.97
52-Wochen-Spanne:
$2.915
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.20 | 6.93M | 0 | -7.03M | -8.20M | -8.9134 |
TMO
Thermo Fisher Scientific Inc
|
448.18 | 166.59B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.81 | 121.74B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.21 | 44.12B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
338.64 | 33.62B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.08 | 32.49B | 7.07B | 1.29B | 993.00M | 4.5355 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
NDRA Q1 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Stage ContinuesEarnings Manipulation Risk - Newser
ENDRA Life Sciences Inc.Common Stock (NQ: NDRA - The Chronicle-Journal
NDRA Stock Price, Quote & Chart | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
NDRA News | ENDRA LIFE SCIENCES INC (NASDAQ:NDRA) - ChartMill
Endra Life Sciences reports Q1 EPS ($1.09) vs. ($1.86) last year - TipRanks
NDRA Strengthens Clinical Foundation for TAEUS Liver Technology - GuruFocus
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ENDRA Life Sciences (NASDAQ: NDRA) faces Nasdaq equity notice after Q1 loss - Stock Titan
ENDRA Life Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
ENDRA Life (NDRA) Q4 2025 Results Miss Estimates — EPS $-3.26 vs $-1.25Expert Stock Picks - Newser
NDRA Q1'26 Earnings: EPS estimate is (1.23) USD - TradingView
Endra Life Sciences (NDRA) Achieves Promising Results with TAEUS Liver - GuruFocus
Endra Life Sciences reports multi-site validation of TAEUS Liver device - TipRanks
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accu - PharmiWeb.com
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility - BioSpace
ENDRA reports multi-site validation results for liver imaging device - Investing.com UK
ENDRA reports multi-site validation results for liver imaging device By Investing.com - Investing.com Australia
Liver Device Demonstrating MRI-like Accuracy and Reproducibility - Business Wire
TradingKey - TradingKey
ENDRA Life Sciences (NASDAQ: NDRA) Heats Up as Diagnostic Play - openPR.com
Is ENDRA Life (NDRA) stock suitable for your portfolio? (Nudges Down) 2026-04-27Senior Analyst Forecasts - Newser
ENDRA Life Sciences (NDRA) price target decreased by 10.00% to 27.54 - MSN
ENDRA Life (NDRA) Stock Chart | Q4 2025: Earnings Fall ShortFree Cash Margin - Xã Châu Thành
ENDRA Life Sciences Faces Renewed Nasdaq Listing Compliance Risk - The Globe and Mail
ENDRA Life Sciences Inc. Files Form 8-K with SEC – Company Details, Address, and Compliance Information (April 2026) 23 - Minichart
Endra Life Sciences receives Nasdaq delisting notice over equity requirement - Investing.com
ENDRA Life Sciences Received Notice of Delisting - TradingView
Equity shortfall puts ENDRA Life Sciences (NASDAQ: NDRA) at renewed Nasdaq delisting risk - Stock Titan
ENDRA Life (NDRA) Stock: Price Action (Declines) 2026-04-20Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS Registered Liver Imaging Technology - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology - Barchart.com
Aug Fed Impact: What is the PEG ratio of ENDRA Life Sciences IncMarket Movers & Fast Momentum Entry Tips - baoquankhu1.vn
Is ENDRA Life (NDRA) Stock Good for Portfolio | Price at $4.95, Down 6.78%Volatility Skew - Newser
Aug Fed Impact: Whats the MACD signal for ENDRA Life Sciences IncGDP Growth & Long-Term Safe Investment Ideas - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Is ENDRA Life (NDRA) Stock Near Resistance | Price at $5.10, Down 4.49%Smart Money Flow - Newser
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 Imaging Bottleneck With TAEUS® as Stocks Under $5 Gain Attention Inside - Barchart
ENDRA Life Sciences (NASDAQ: NDRA) Targets MASLD and GLP-1 - openPR.com
Retail Surge: Is ENDRA Life Sciences Inc exposed to currency risks2026 Price Swings & AI Forecasted Entry/Exit Points - baoquankhu1.vn
ENDRA Life Sciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView — Track All Markets
ENDRA (NDRA) Optimistic About TAEUS Technology's Potential - GuruFocus
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):